Hear what your colleagues are saying about IYUZEH™

Experienced professionals who follow the latest advancements in eye care have a lot to say about IYUZEH™ (latanoprost ophthalmic solution) 0.005%, the first and only preservative-free latanoprost for patients with open-angle glaucoma (OAG) and ocular hypertension (OHT).

Doctor Jason Bacharach discusses the significance of the IYUZEH efficacy study. Play video. Jason M. Bacharach, MD discusses the significance of the IYUZEH efficacy study
Doctor Jason Bacharach discusses how preservative-free latanoprost may contribute to compliance. Play video. Jason M. Bacharach, MD Discusses how Preservative-free Treatment May Contribute to Compliance
Doctor Michael Chaglasian discusses his experience with Iyuzeh. Play video. Michael Chaglasian, OD, FAAO talks about why IYUZEH is a Game-Changing Treatment
Jade Coats, OD discusses the connection between patient satisfaction and adherence. Play video. Jade Coats, OD Discusses the connection between Patient satisfaction and adherence
Christopher Lievens, OD, MS, PhD explains why he's excited to prescrive a preservative-free latanoprost. Play video. Christopher Lievens, OD, MS, PhD Explains why he's excited to Prescribe a Preservative-Free Latanoprost
Mitch Ibach, OD, FAAO talks about the importance of efficacy and managing open-angle glaucoma. Play video. Mitch Ibach, OD, FAAO Talks about the importance of Efficacy and Managing Open-Angle Glaucoma

All the eye care professionals featured in these videos are paid consultants of Thea Pharma Inc.